Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
19.28
+0.23 (1.21%)
At close: Dec 5, 2025, 4:00 PM EST
19.07
-0.21 (-1.09%)
After-hours: Dec 5, 2025, 6:19 PM EST
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Sabra Health Care REIT stock have an average target of 20.56, with a low estimate of 20 and a high estimate of 22. The average target predicts an increase of 6.64% from the current stock price of 19.28.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Sabra Health Care REIT stock from 9 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 4 | 4 | 5 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $20 → $21 | Buy | Maintains | $20 → $21 | +8.92% | Nov 25, 2025 |
| UBS | UBS | Hold Initiates $20 | Hold | Initiates | $20 | +3.73% | Nov 18, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $21 → $20 | Buy | Maintains | $21 → $20 | +3.73% | Oct 21, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates $20 | Hold | Initiates | $20 | +3.73% | Oct 1, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $18 → $20 | Hold | Maintains | $18 → $20 | +3.73% | Sep 3, 2025 |
Financial Forecast
Revenue This Year
756.74M
from 702.64M
Increased by 7.70%
Revenue Next Year
810.24M
from 756.74M
Increased by 7.07%
EPS This Year
0.76
from 0.54
Increased by 41.19%
EPS Next Year
0.79
from 0.76
Increased by 3.34%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 821.0M | 992.7M | ||||
| Avg | 756.7M | 810.2M | ||||
| Low | 692.7M | 550.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 16.8% | 31.2% | ||||
| Avg | 7.7% | 7.1% | ||||
| Low | -1.4% | -27.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.85 | 0.88 | |
| Avg | 0.76 | 0.79 | |
| Low | 0.69 | 0.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 57.5% | 15.7% | |
| Avg | 41.2% | 3.3% | |
| Low | 27.0% | -6.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.